|
Rheumatoid Arthritis
|
0.090 |
Biomarker
|
disease |
BEFREE |
One lgG1, lambda monoclonal antibody (FKN-E12), was derived from synovial B lymphocytes of a patient with sero-negative RA.
|
10441171 |
1999 |
|
Encephalitis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system.
|
10640747 |
2000 |
|
Hirschsprung Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recently, germline mutations of RET, GDNF, and NTN genes have been reported in HSCR.
|
10946353 |
2000 |
|
Aganglionosis, Colonic
|
0.020 |
Biomarker
|
disease |
BEFREE |
Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement.
|
10946353 |
2000 |
|
Paraganglioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
|
10998441 |
2000 |
|
Pheochromocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
|
10998441 |
2000 |
|
Adrenal Gland Pheochromocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
|
10998441 |
2000 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Collectively, these results indicate that local injections with OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of the Th1-type cytokines and CXC3 chemokines.
|
10999462 |
2000 |
|
Aganglionosis, Colonic
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Relationship between the type of RET/GDNF/NTN or SOX10 gene mutations and long-term results after surgery for total colonic aganglionosis with small bowel involvement.
|
11685702 |
2001 |
|
Prion Diseases
|
0.200 |
Biomarker
|
group |
RGD |
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
|
11870871 |
2002 |
|
Hypertensive disease
|
0.040 |
Biomarker
|
group |
LHGDN |
CX(3)C chemokine fractalkine in pulmonary arterial hypertension.
|
12016106 |
2002 |
|
Chronic mesangial proliferative glomerulonephritis
|
0.200 |
Biomarker
|
disease |
RGD |
Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis.
|
12028445 |
2002 |
|
Borna Disease
|
0.200 |
Biomarker
|
disease |
RGD |
Upregulation of chemokine receptor gene expression in brains of Borna disease virus (BDV)-infected rats in the absence and presence of inflammation.
|
12053272 |
2002 |
|
Inflammation
|
0.040 |
Biomarker
|
phenotype |
LHGDN |
Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion.
|
12100035 |
2002 |
|
Arteriosclerosis
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus.
|
12551893 |
2003 |
|
Virus Diseases
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus.
|
12551893 |
2003 |
|
HIV Infections
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Increased intrathecal release of soluble fractalkine in HIV-infected patients.
|
12639246 |
2003 |
|
Inflammation
|
0.040 |
AlteredExpression
|
phenotype |
LHGDN |
CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
|
12667665 |
2003 |
|
Inflammatory Bowel Diseases
|
0.040 |
Biomarker
|
group |
BEFREE |
The chemokine gene cluster [CCL22, CX3CL1, CCL17] (previously known as [SCYA22, SCYD1, SCYA17]) is a candidate locus for one of the susceptibility genes for inflammatory bowel disease that are located in the peri-centromeric region of chromosome 16.
|
12940913 |
2003 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
LHGDN |
Fractalkine in vascular biology: from basic research to clinical disease.
|
12969992 |
2004 |
|
Inflammation
|
0.040 |
Biomarker
|
phenotype |
LHGDN |
Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways.
|
14514721 |
2003 |
|
Multiple Sclerosis
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Although CX3CL1 expression is upregulated in cultured astrocytes in response to proinflammatory cytokines, no evidence for expression differences of CX3CL1 between control patients and MS patients was found.
|
14533779 |
2003 |
|
Multiple Sclerosis
|
0.060 |
AlteredExpression
|
disease |
LHGDN |
Although CX3CL1 expression is upregulated in cultured astrocytes in response to proinflammatory cytokines, no evidence for expression differences of CX3CL1 between control patients and MS patients was found.
|
14533779 |
2003 |
|
Glomerulonephritis
|
0.200 |
Biomarker
|
disease |
RGD |
This study investigated the potential of MCs to synthesize CX3CL1/fractalkine, a CX3C chemokine, both in vitro and in acute anti-Thy1 glomerulonephritis in rats.
|
14605272 |
2003 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The effect of CX3CR1 on tumor growth required host cytotoxic effector cell functions because both IFNgamma-/- and perforin-/- mice were resistant to CX3CL1 antitumor effect.
|
14612547 |
2003 |